Complementary methodologies for rare cancers: Worth discussing?
Wednesday, October 15, 2014 - 12:02
in Health & Medicine
Rare Cancers Europe (RCE) is a multi stakeholder initiative promoted by ESMO dedicated to putting rare cancers on the European political agenda. In their consensus document, RCE argue that a higher degree of uncertainty should be accepted for regulatory as well as clinically informed decision-making in rare cancers, to overcome the limitations imposed by small population trials.